- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 36.2930 ↑ 0.3%
[as on 20 October, 2025]
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
Returns
Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
---|
Tata India Pharma & Healthcare Fund-Direct Plan-Growth | -1.29% | 0.3% | 1.1% | -0.55% | 1.41% | 1.45% | 24.68% | 19.85% | 21.46% | - |
Portfolio
Asset allocation
Equity | Debt | Realestate | Commodities | Cash & Equivalents |
---|
98.28% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.72% |
Equity
Name | Sector | Weight % |
---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals & Biotechnology | 10.03% |
APOLLO HOSPITALS ENTERPRISE LTD. | Healthcare Services | 5.06% |
LUPIN LTD. | Pharmaceuticals & Biotechnology | 4.88% |
CIPLA LTD. | Pharmaceuticals & Biotechnology | 4.86% |
TORRENT PHARMACEUTICALS LTD. | Pharmaceuticals & Biotechnology | 4.68% |
HEALTHCARE GLOBAL ENTERPRISES LTD. | Healthcare Services | 4.68% |
ASTER DM HEALTHCARE LTD. | Healthcare Services | 4.63% |
ALKEM LABORATORIES LTD. | Pharmaceuticals & Biotechnology | 4.46% |
MAX HEALTHCARE INSTITUTE LTD. | Healthcare Services | 3.95% |
DIVI LABORATORIES LTD. | Pharmaceuticals & Biotechnology | 3.86% |
WOCKHARDT LTD. | Pharmaceuticals & Biotechnology | 3.22% |
IPCA LABORATORIES LTD. | Pharmaceuticals & Biotechnology | 3.20% |
METROPOLIS HEALTHCARE LTD. | Healthcare Services | 2.98% |
AJANTA PHARMA LTD. | Pharmaceuticals & Biotechnology | 2.97% |
DR. LAL PATH LABS LTD. | Healthcare Services | 2.94% |
ABBOTT INDIA LTD. | Pharmaceuticals & Biotechnology | 2.90% |
RAINBOW CHILDRENS MEDICARE LTD. | Healthcare Services | 2.82% |
PI INDUSTRIES LTD. | Fertilizers & Agrochemicals | 2.64% |
DR. AGARWALS HEALTH CARE LTD. | Healthcare Services | 2.39% |
MANKIND PHARMA LTD | Pharmaceuticals & Biotechnology | 2.33% |
FDC LTD. | Pharmaceuticals & Biotechnology | 2.14% |
FORTIS HEALTHCARE LTD. | Healthcare Services | 1.91% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD. | Healthcare Services | 1.77% |
SYNGENE INTERNATIONAL LTD. | Healthcare Services | 1.73% |
DR REDDYS LABORATORIES LTD. | Pharmaceuticals & Biotechnology | 1.71% |
NIVA BUPA HEALTH INSURANCE COMPANY LTD. | Insurance | 1.58% |
VIJAYA DIAGNOSTIC CENTRE LTD. | Healthcare Services | 1.55% |
AUROBINDO PHARMA LTD. | Pharmaceuticals & Biotechnology | 1.41% |
SAI LIFE SCIENCES LTD | Pharmaceuticals & Biotechnology | 1.08% |
COHANCE LIFESCIENCES LTD. | Pharmaceuticals & Biotechnology | 1.02% |
AKUMS DRUGS AND PHARMACEUTICALS LTD | Pharmaceuticals & Biotechnology | 0.88% |
HIKAL LTD. | Pharmaceuticals & Biotechnology | 0.76% |
MEDPLUS HEALTH SERVICES LTD. | Retailing | 0.69% |
PFIZER LTD. | Pharmaceuticals & Biotechnology | 0.41% |
KRSNAA DIAGNOSTICS LTD. | Healthcare Services | 0.08% |
INDOCO REMEDIES LTD. | Pharmaceuticals & Biotechnology | 0.04% |
LAXMI DENTAL LIMITED | Healthcare Equipment & Supplies | 0.04% |
Portfolio data is as on date 30 September, 2025
NAV (Net asset value) history
Tata India Pharma & Healthcare Fund-Direct Plan-Growth - 30 days NAV history
Date | NAV |
---|
20 October, 2025 | 36.2930 |
17 October, 2025 | 36.1836 |
16 October, 2025 | 35.9814 |
15 October, 2025 | 35.7586 |
14 October, 2025 | 35.7266 |
13 October, 2025 | 35.8974 |
10 October, 2025 | 35.9402 |
9 October, 2025 | 35.6319 |
8 October, 2025 | 35.4186 |
7 October, 2025 | 35.5454 |
6 October, 2025 | 35.5216 |
3 October, 2025 | 35.1938 |
1 October, 2025 | 35.2677 |
30 September, 2025 | 34.9938 |
29 September, 2025 | 34.9862 |
26 September, 2025 | 34.9687 |
25 September, 2025 | 35.5776 |
24 September, 2025 | 35.7775 |
23 September, 2025 | 35.9827 |
22 September, 2025 | 36.1388 |
19 September, 2025 | 36.4949 |
18 September, 2025 | 36.1627 |
17 September, 2025 | 36.0255 |
16 September, 2025 | 36.0774 |
15 September, 2025 | 36.0199 |
12 September, 2025 | 36.1435 |
11 September, 2025 | 36.1258 |
10 September, 2025 | 36.0439 |
9 September, 2025 | 35.8110 |
8 September, 2025 | 35.7362 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 36.2930 as on 20 October, 2025.
What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are -1.29% as on 20 October, 2025.
What are 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 1.45% as on 20 October, 2025.
What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 24.68% as on 20 October, 2025.
What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 19.85% as on 20 October, 2025.